Performance analysis of BriaCell Therapeutics Corp Warrant (BCTXZ)
Annual Return
Since Apr 25, 2025, BCTXZ has had an average annual return of -87.51%, underperforming the benchmark SPY, which returned +29.56% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -65.64% | -77.85% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -34.45% | -11.91% | -16.42% | -33.96% | -13.46% | +18.49% | +5.11% | -65.64% | |||||
| 2025 | -16.03% | -0.45% | -3.19% | -71.71% | -46.61% | +109.25% | +34.30% | -19.98% | -19.40% | -77.85% |
Drawdown analysis of BriaCell Therapeutics Corp Warrant (BCTXZ)
The maximum drawdown for the BCTXZ was -93.96%, occurring on Jun 24, 2026. This drawdown has not yet recovered.
The current BCTXZ drawdown is -92.39%.
Since Apr 25, 2025 BCTXZ has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -93.96% | Apr 25, 2025 | 291 | Jun 24, 2026 | Ongoing | Ongoing | Ongoing |